The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports
IL-23 inhibitors and AbbVie’s Rinvoq are projected to have the largest growth in the coming months EXTON, Pa., October 13, 2022 /PRNewswire/ – TNF inhibitors continue to be the mainstay for treating psoriatic arthritis (PsA), largely driven by the gold standards, etanercept and adalimumab. However, the recent entrance of IL-23 inhibitors (Janssen’s Tremfya and AbbVie’s […]
US Ophthalmologists Report Increasing Trial of Roche/Genentech’s Vabysmo in Diabetic Macular Edema, Though Regeneron’s Eylea Maintains Its Strong Positioning, According to Spherix Global Insights
Coherus’ new ranibizumab biosimilar, Cimerli, and the anticipated 8mg aflibercept formulation are predicted to further shake up the DME landscape in 2023 EXTON, Pa., October 12, 2022 / PRNewswire / – Now on the market for over nine months, Roche/Genentech’s Vabysmo (faricimab-svoa) has had success in expanding the breadth of users. However, depth of use […]
AbbVie’s Humira Safety Net in Inflammatory Bowel Disease is Coming Through Strong, Creating New Threats to Existing Competitors, According to Spherix Global Insights
Rinvoq and Skyrizi are making waves in ulcerative colitis and Crohn’s disease; is Takeda’s Entyvio in the hot seat? EXTON, Pa., October 6, 2022 /PRNewswire/ – Over the course of this year, AbbVie has proven successful in expanding their immunology portfolio to offset potential Humira losses with the impending launch of adalimumab biosimilars in January […]
Generalized Myasthenia Gravis Pipeline Assessment Unveils Top Contenders to Challenge Current Market Biologics – New Spherix Report
High interest in argenx’s SC efgartigimod, Sanofi’s tolebrutinib, Genentech’s satralizumab, and Horizon’s inebilizumab Exton, Pa., October 6, 2022 /PRNewswire/ – The recent launches of argenx’s Vyvgart and Alexion’s Ultomiris for the treatment of generalized myasthenia gravis (gMG), a debilitating and chronic autoimmune neuromuscular disorder, have provided patients with a new mechanism of action and new […]
Spherix Global Insights Delivers Cheeriodicals to Nemours Children’s Hospital, Delaware
Friday, September 23, 2022–Colleagues from Spherix Global Insights partnered with Cheeriodicals to assemble and deliver Big Green Boxes of Cheer to pediatric patients at Nemours Children’s Hospital, Delaware. A team of nearly 75 employees from Spherix Global Insights came together to volunteer their time to pack more than 200 Big Green Boxes of Cheer for […]
Soaring 76 rankings 2022: Greater Philadelphia’s fastest-growing companies, Nos. 26-50
The economy may have taken some unexpected twists and turns over the past couple of years, but it didn’t stop local companies from continuing to grow. If anything, a number of companies found creative ways to meet the needs of clients and not only grow their own businesses but other businesses, too. Each year the […]
Despite Amplified Use of SGLT2 Inhibitors for Glomerular Diseases, EU and US Nephrologists Express a Continued Strong Desire for New Treatment Options for FSGS Patients, Spherix Reports
Nephrologists are most anticipating sparsentan (Travere, co-marketed with Vifor in EU), with Vertex’s pipeline product VX-147 following closely behind – according to new research from Spherix Global Insights EXTON, Pa., September 21, 2022 /PRNewswire/ — Focal segmental glomerulosclerosis (FSGS) is one of the leading causes of nephrotic syndrome across the world and is considered the […]
Geographic Atrophy — A Look Into Clinical Development
Throughout my career in the ophthalmology field, I have come face to face with patients suffering from geographic atrophy (GA) and have witnessed firsthand the devastating impact it can have among those patients. I’ve grown passionate about educating others about the potential signs, symptoms, and consequences of GA, as well as the major risk factors […]
Economic Burden Forces Shift in Specialty Physicians’ Treatment Decisions and Relationship with Pharma
Over the past year, countries across the globe have reported multi-decade highs in inflation, with the United States recording its highest inflation rate in 40 years.1 The unprecedented rise in inflation is causing financial and economic strain on many households and businesses, resulting in a behavioral shift in consumers across the country. The U.S Bureau of […]
Economic Burden Forces Shift in Specialty Physicians’ Treatment Decisions and Relationship with Pharma, According to New Spherix Report
The inflationary economy and lasting effects of COVID-19 have caused staff and product shortages, a rise in labor costs, and increased patient sensitivity to medication costs EXTON, Pa., September 12, 2022 /PRNewswire/ — Over the past year, many countries have reported multi-decade highs in inflation, with the United States recording its highest inflation rate in […]
